NEW YORK, June 27, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the NASDAQ Closing Cross was used for the eleventh consecutive year to rebalance NASDAQ-listed securities in the entire family of U.S. Russell indexes during their annual reconstitution.
2014 fiscal year projected revenue increased from range of $28 to $30 million to range of $36 to $40 million
2014 fiscal year projected adjusted EBITDA margin increased from 55% to 60%
Projecting forward looking twelve month revenue run rate of $56 - $60 million
Projecting forward looking twelve month adjusted EBITDA run rate of $36 - $40 million
Two cornerstone licensees for Avia and AND1 renewed and extended before Closing
Total future contractual guaranteed royalty minimums in excess of $200 million from all twelve brands in the Company's portfolio
NEW YORK, Aug.
This past quarter saw the execution of Rediff.com’s strategy: to retain
and grow its approximately 15 million engaged users through a variety of
digital offerings and then earn revenue from digital services provided
to these users and to businesses.
Company posts fifth consecutive profitable quarter For the three months ended June 30, 2014, revenues totaled $907,302 while income from operations was $55,148. The major components of revenues, cost of sales, selling, general and administrative expenses are discussed in the 10-Q
The 10-Q can be found at http://www.sec.gov MINNETONKA, Minn.
Physicians Realty Trust (NYSE:DOC) (the “Company,” the “Trust,” “we,”
“our” and “us”), a self-managed healthcare real estate investment trust,
today announced results for the second quarter ended June 30, 2014.
Patent Properties, Inc. (OTCQB:PPRO) (“Patent Properties” or the
“Company”), an intellectual property company that develops and
commercializes its unique portfolio of assets and is creating a
disruptive licensing solution for the mass market of patent owners and
users, today announced second quarter 2014 results.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.